bioRxiv Science⌕ Search

Biology subjects

Xin, G.

Publications and source records attributed to Xin, G..

7 recordsLinked to original sources

NuSAP participates in metaphase spindle length control in mammalians

Precise chromosome congression and segregation require proper assembly of a steady-state metaphase spindle, which is dynamic and maintained by continuous microtubule flux. NuSAP is a microtubule-stabilizing and -bundling protein that promotes chromosomedependent spindle assembly. However, its function in spindle dynamics remains unclear. Here, we demonstrate that NuSAP regulates the dynamics and length control of the metaphase spindle. Mechanistically, NuSAP facilitates kinetochore capture and spindle assembly via promoting Eg5 binding with microtubules. It also prevents excessive microtubule depolymerization through interacting with Kif2A and reduces its spindle-pole localization. NuSAP is phosphorylated by Aurora A at Ser-240 during mitosis, and this phosphorylation promotes its interaction with Kif2A on the spindle body and reduces its localization to the spindle poles, thus maintaining the proper spindle microtubule flux. NuSAP knockout resulted in shorter spindle formation with faster microtubule flux and chromosome misalignment. Taken together, we uncover that NuSAP participates in spindle assembly, dynamics, and metaphase spindle length control via affecting microtubule flux and Kif2A localization.

cell biology↗

Biphasic response of CD8 T cell to asparagine restriction maximizes its metabolic fitness and antitumoral functionality

Robust and effective T cell immune surveillance and cancer immunotherapy require properly allocating metabolic resources to sustain energetically costly processes, including growth and cytokine production. Amino acids are major cellular constituents that serve as protein building blocks, energy sources, and signaling molecules. Although T cells can synthesize all nonessential amino acids, including asparagine (Asn), activated CD8 T cells still consume considerable quantities of exogenous Asn. Unexpectedly, Asn restriction on CD8 T cells induced a biphasic response, consisting of sequential actions with opposing effects at two conceptually separated phases after activation. Asn restriction suppressed activation and cell cycle entry in the early phase by depleting the intracellular Asn pool while rapidly engaging an ATF4/NRF2-dependent stress response, conferring robust proliferation and effector function of CD8 T cells in the late phase. Mechanistically, ATF4 and NRF2 activation rendered CD8 T cells to utilize de novo biosynthesis of Asn, consuming less glucose and glutamine but producing more intracellular nucleotides for proliferation. Moreover, NRF2 activation promoted the expression of inflammatory and effector genes to enhance effector functions in CD8 T cells. Accordingly, Asn restriction or overexpression of ATF4 or NRF2 potentiated T cell-mediated antitumoral response in the metabolically restricted tumor microenvironment. Our studies revealed Asn as a critical metabolic node in directing the stress signaling to shape T cell metabolic fitness and effector functions. Asn restriction is a promising and clinically relevant strategy to enhance cancer immunotherapy.

immunology↗

LRT: T Cell Trajectory Inference by Integrative Analysis of Single Cell TCR-seq and RNA-seq data

Single-cell RNA sequencing (scRNA-seq) data has been widely used for cell trajectory inference, with the assumption that cells with similar expression profiles share the same differentiation state. However, the inferred trajectory may not reflect true clonal relationships among cells. Single-cell T cell receptor sequencing (scTCR-seq) data provides invaluable insights into the clonal relationship among cells, yet it lacks functional characteristics. Therefore, scRNA-seq and scTCR-seq data complement each other in improving trajectory inference, where a reliable computational tool is still missing. We developed LRT, a computational framework for the integrative analysis of scTCR-seq and scRNA-seq data for T cell trajectory inference. Specifically, LRT utilizes the TCR sequence information to identify clonally related cells and then uses the transcriptomics information from scRNA-seq data to construct clonotype-level cell trajectories. LRT provides a comprehensive analysis workflow, including preprocessing, cell trajectory clustering, pseudotime inference, and marker gene identification. We illustrated its utility using scRNA-seq and scTCR-seq data of CD4+ T cells with acute lymphocytic choriomeningitis virus infection, where we could identify cell trajectories that cannot be revealed solely based on scRNA-seq data. Our downstream analyses showed that (i) these trajectories are involved in distinct functional roles; (ii) the expression patterns of their marker genes over the estimated pseudotime nicely coincide with the Th1/Tfh biology that is well established for the CD4+ T cell differentiation; and (iii) the higher level of TCR sequence similarities was observed within each cluster, compared to between clusters. The LRT framework was implemented as an R package LRT, and it is now publicly accessible at https://github.com/JuanXie19/LRT. In addition, it provides two Shiny apps shinyClone and shinyClust that allow users to interactively explore distributions of clonotypes, conduct repertoire analysis, implement clustering of cell trajectories, and predict cell trajectory cluster marker genes. Author SummaryUnderstanding the dynamic changes behind biological processes is important for determining molecular mechanisms underlying normal tissue formulation, developmental disorders and pathologies. Usually, a biological process can be characterized by identifying a trajectory, a path that goes through the various cellular states associated with the process. Since cells in different states may express different sets of genes, researchers often infer cell trajectory via capturing transcriptomics changes. Dozens of methods have been developed for cell trajectory inference, and scRNA-seq data is predominantly utilized. However, methods based only on scRNA-seq data cannot tell us if cells from the same trajectory come from the same clone or not. T cells play a key role in the immune system, and their high antigen recognition specificity is largely determined by their TCR sequences. Thanks to the advent of scTCR-seq technology, people can identify the group of cells coming from the same clone. This paper describes our novel computational framework, namely LRT, and demonstrates that by complementing scRNA-seq data with the clonal information from scTCR-seq data using LRT, we are able to identify cell trajectories that cannot be revealed solely based on scRNA-seq data.

bioinformatics↗

Mice infected with Mycobacterium tuberculosis are resistant to secondary infection with SARS-CoV-2

Mycobacterium tuberculosis (Mtb) and SARS-CoV-2 (CoV2) are the leading causes of death due to infectious disease. Although Mtb and CoV2 both cause serious and sometimes fatal respiratory infections, the effect of Mtb infection and its associated immune response on secondary infection with CoV2 is unknown. To address this question we applied two mouse models of COVID19, using mice which were chronically infected with Mtb. In both model systems, Mtb-infected mice were resistant to secondary CoV2 infection and its pathological consequences, and CoV2 infection did not affect Mtb burdens. Single cell RNA sequencing of coinfected and monoinfected lungs demonstrated the resistance of Mtb-infected mice is associated with expansion of T and B cell subsets upon viral challenge. Collectively, these data demonstrate that Mtb infection conditions the lung environment in a manner that is not conducive to CoV2 survival. AUTHOR SUMMARYMycobacterium tuberculosis (Mtb) and SARS-CoV-2 (CoV2) are distinct organisms which both cause lung disease. We report the surprising observation that Mtb-infected mice are resistant to secondary infection with CoV2, with no impact on Mtb burden and resistance associating with lung T and B cell expansion.

immunology↗

Endothelial Rap1B mediates T-cell exclusion to promote tumor growth -a novel mechanism underlying vascular immunosuppression

Overcoming vascular immunosuppression: lack of endothelial cell (EC) responsiveness to inflammatory stimuli in the proangiogenic environment of tumors, is essential for successful cancer immunotherapy. The mechanisms through which Vascular Endothelial Growth Factor (VEGF) modulates tumor EC response to exclude T cells are not well understood. The goal was to determine the role of EC Rap1B, a small GTPase that positively regulates VEGF- angiogenesis during development, in tumor growth in vivo. Using mouse models of Rap1B deficiency, Rap1B+/- and EC-specific Rap1B KO (Rap1Bi{Delta}EC) we demonstrate that EC Rap1B restricts tumor growth and angiogenesis. More importantly, EC-specific Rap1B deletion leads to an altered tumor microenvironment with increased recruitment of leukocytes and increased activity of tumor CD8+ T cells. We find that tumor growth, albeit not angiogenesis, is restored in Rap1Bi{Delta}EC mice by depleting CD8+ T cells. Mechanistically, global transcriptome analysis indicated upregulation of the tumor cytokine, TNF-, -induced signaling and NF{kappa}B transcriptional activity in Rap1B-deficient ECs. Functionally, EC Rap1B deletion led to upregulation of NF{kappa}B activity and enhanced Cell Adhesion Molecules (CAMs) expression in TNF- stimulated ECs. Importantly, CAM expression was upregulated also in tumor ECs from Rap1Bi{Delta}EC mice, vs. controls. Significantly, deletion of Rap1B abrogated VEGF immunosuppressive downregulation of CAM expression, demonstrating that Rap1B is essential for VEGF-suppressive signaling. Thus, our studies identify a novel endothelial-endogenous mechanism underlying VEGF-dependent desensitization of EC to pro-inflammatory stimuli. Significantly, they identify EC Rap1 as a potential novel vascular target in cancer immunotherapy.

cancer biology↗

Succinate dehydrogenase/complex II is critical for metabolic and epigenetic regulation of T cell proliferation and inflammation

Robust and effective T cell-mediated immune responses require the proper allocation of metabolic resources to sustain energetically costly processes like growth, proliferation, and cytokine production. Epigenetic control of the genome also governs T cell transcriptome and T cell lineage commitment and maintenance. Cellular metabolic programs interact with epigenetic regulation by providing substrates for covalent modifications of chromatin. By employing complementary genetic, epigenetic, and metabolic approaches, we revealed that tricarboxylic acid (TCA) cycle flux fuels biosynthetic processes while controlling the ratio of -ketoglutarate/succinate to modulate the activities of dioxygenases that are critical for driving T cell inflammation. In contrast to cancer cells, where succinate dehydrogenase (SDH)/complex II inactivation drives cell transformation and growth, SDH/complex II deficiency in T cells causes proliferation and survival defects when the TCA cycle is truncated, blocking carbon flux to support nucleosides biosynthesis. Accordingly, replenishing the intracellular nucleoside pool partially relieved the dependence of T cells on SDH/complex II for proliferation and survival. Conversely, SDH deficiency induces a pro-inflammatory gene signature in T cells and promotes T helper 1 (TH1) and T helper 17 (TH17) lineage differentiation. Mechanistically, the hypoxia-inducible factor 1 (HIF-1) is not required for succinate-induced inflammation in T cells. A reduced -ketoglutarate/succinate ratio in SDH deficient T cells promotes inflammation through changing the pattern of the transcriptional and chromatin-accessibility signatures and consequentially increasing the expression of the transcription factor, B lymphocyte-induced maturation protein-1 (Blimp-1). Collectively, our studies revealed a critical role of SDH/complex II in allocating carbon resources for anabolic processes and epigenetic regulation in T cell proliferation and inflammation.

immunology↗

The mitochondrial deubiquitinase USP30 regulates AKT/mTOR signaling

Mitophagy is an intracellular mechanism to maintain mitochondrial health by removing dysfunctional mitochondria. The E3 ligase Parkin ubiquitinates the membrane proteins on targeted mitochondria to initiate mitophagy, and USP30 antagonizes this Parkin-dependent mitophagy. AKT/mTOR signaling is a master regulator of cell proliferation, differentiation, survival, and growth. Although mounting evidence showed mitophagy and AKT/mTOR signaling interact with each other during mitophagy, the specific mechanisms between Parkin/USP30 and AKT/mTOR signaling have not been elucidated. This research artificially expressed Parkin and USP30 in Hela cells and compared AKT/mTOR and apoptosis signals between Hela cells, HeLa Parkin cells, and Hela Parkin USP30 cells during mitophagy. The studys results suggest that Parkin promotes AKT degradation via ubiquitination, which induces cell apoptosis during mitochondrial stress. On the contrary, USP30 protects AKT via deubiquitination. These findings provide new insights into Parkin and USP30s role in cell apoptosis and physiological and pathological functions of USP30 beyond mitophagy.

pharmacology and toxicology↗